Abstract Plasmid vectors used for mammalian expression or for in vitro cRNA translation can differ substantially and are rarely cross-compatible. To make comparisons between mammalian and Xenopus oocyte expression systems, it would be advantageous to use a single vector without the need for shuttle vectors or subcloning. We have designed such a vector, designated pUNIV for universal, with elements that will allow for in vitro or ex vivo expression in multiple cell types. We tested the expression of pUNIVbased cDNA cassettes using enhanced green fluorescent protein and two forms of the type A γ-aminobutyric acid receptor (GABA A R) and compared pUNIV to vectors optimized for expression in either Xenopus oocytes or mammalian cells. In HEK293 cells, radioligand binding was robust, and patch clamp experiments showed that subtle macroscopic GABA A R kinetics were indistinguishable from our previous results. In Xenopus oocytes, agonist median effective concentration measurements matched previous work using a vector optimized for oocyte expression. Furthermore, we found that expression using pUNIV was significantly enhanced in oocytes and was remarkably long-lasting in both systems.
Introduction
Proteins have been produced in a multitude of heterologous expression systems, including bacteria, yeast, plant tissue, and vertebrate cells [37] . The oocyte of Xenopus laevis has been a useful expression system for many proteins of interest [45] , and a variety of mammalian cells lines are also available for ex vivo studies of protein function. In the neurosciences, laboratories studying ion channels often use these cells for characterization of conductances resulting from voltage steps, as with voltage-dependent ion channels or from application of agonists or drugs. We study a member of the ligand-gated ion channel superfamily (which includes acetylcholine, glycine, and serotonin receptor subtypes) the γ-aminobutyric acid receptor (GABA A R). This receptor is ubiquitous in the mammalian central nervous system and has homologues in other vertebrates and invertebrates [48] . It is composed of five subunits, from a diversity of subtypes, arranged pseudosymmetrically around a chloride-conducting pore. In the central nervous system, the most common stoichiometry for GABA A Rs is two α, two β, and one γ subunit [46] . However, α and β subunits can also assemble to form functional GABA A Rs without addition of the γ subunit [44, 47] .
Mutational studies of the GABA A R have commonly been performed using Xenopus oocytes. Some mutations cause a severe reduction in GABA-gated currents, making high expression levels desirable. In addition, some studies require fast agonist application rates, such that the relatively large (∼1-mm diameter) oocyte becomes impossible to superfuse rapidly enough to observe actual current rise times. For these studies, it behooves us to use smaller cells, such as transformed mammalian HEK293 cells. However, moving mutations of interest from one vector optimized for oocyte expression to a mammalian-specific expression vector requires additional effort of subcloning or redundant mutagenesis. Therefore, we designed and tested a single vector (pUNIV for universal) to yield high level, stable expression in multiple cell types.
The oocyte expression vector pGH19 (a derivative of pGEMHE: [31, 39] ) includes both 5′-and 3′-untranslated regions (UTRs) from the Xenopus β-globin gene [28] to stabilize injected cRNA and thereby boost expression several-fold [31, 43] . It has been demonstrated that polyadenylation signals also stabilize cRNA transcripts in oocytes beyond 48 h [12] , and slight changes in the 5′-UTR sequence can impact stability [43] . Along with the 3′-UTR from pGH19, pUNIV uses the alfalfa mosaic virus (AMV) coat protein (RNA 4) 5′-UTR. This AMV sequence has been shown to enhance in vitro translation [25] and expression of cRNA in oocyte studies [9, 33] , as well as in plant and bacterial expression systems [10, 14, 15] . We show that the combination of AMV plus β-globin stabilization boosts expression, compared to already high-level expression vectors for Xenopus oocytes and mammalian cells. Moreover, in both mammalian and oocyte expression systems, pUNIV expression levels remain elevated for days or even weeks.
Materials and methods

Plasmid construction
The backbone of pUNIV (Fig. 1) is the mammalian expression vector pCI-neo (Promega, Madison, WI), which contains a T7 promoter for in vitro cRNA transcription and a chimeric intron from human β-globin and an immunoglobulin gene heavy chain variable region [6, 22, 42] that may boost expression [8] . The large T-antigen acts on the SV40 origin of replication in pUNIV to allow for transient episomal replication [18, 21, 38] , whereas pCEP4 (Invitrogen, Carlsbad, CA) uses Epstein-Barr viral sequences to promote episomal replication [36] . Both pUNIV and pCEP4 contain cytomegalovirus immediate early enhancer and promoter signals for mammalian expression [41] . cDNA for rat GABA A α1, β2, γ2S (short) and γ2L (long splice variant) subunits were amplified using a 5′ oligonucleotide containing an EcoR I site followed by the AMV sequence segment (GTTTTTATTTTTAATTTTCTTTCAAA TACTTCCACC) immediately before the start methionine of each subunit, and a 3′ primer with an Mlu I site after the stop codon. This sequence was modified from the original, such that if the next base is an adenosine, an Nco I site is formed [25] . However, none of the clones presented here made use of this site, as we did not wish to alter the signal peptide sequence beyond the start methionine (though a version of pUNIV with AMV permanently inserted with an Nco I site could be constructed if desired). Therefore, the AMV was included by polymerase chain reaction (PCR) in the 5′ oligonucleotide as opposed to being placed permanently in the vector. We inserted Xenopus β-globin Fig. 1 pUNIV Construction. pUNIV was derived from the backbone vector pCI-neo, which contains an f1 origin of replication (f1 ori) and an ampicillin resistance gene (Amp r ) for maintenance in ampicillinsensitive bacterial strains (white segments). pCI-neo also contains a neomycin phosphotransferase gene (neo r ) for G418 selection under the control of SV40 enhancer/promoter with an SV40 tail region downstream. This region (gray) also promotes episomal replication when coexpressed with the SV40 large T antigen or when expressed in a T antigen stable cell line. Expression features are highlighted in black. Mammalian expression is driven by the CMV immediate early enhancer/promoter, and cRNA transcription uses T7 RNA polymerase. The chimeric intron between the CMV promoter and the multiple cloning site (MCS) is also depicted (see Materials and methods). The inserted Xenopus β-globin 3′-UTR contains the polyadenlylation signal. DNA of interest is PCR amplified with oligonucleotides designed to add restriction sites for directional subcloning into the MCS. The 5′ oligonucleotide also contains the AMV sequence immediately prior to the start methionine (5′ ATG) in the DNA of interest polyadenylation sequence into the multiple cloning region of pCI-neo, PCR amplified from pGH19 with oligonucleotide primers (courtesy of Paul Gardner, HHMI, University of Chicago) containing Mlu I (5′) and Not I (3′) restrictions sites. We also constructed pUNIV-EGFP with enhanced green fluorescent protein (Clontech, Mountain View, CA) as an independent marker for transfection efficiency.
Mammalian cell culture
Cells were grown on 100-or 35-mm tissue culture dishes in minimum essential medium with Earle's salts (Life Technologies) containing 10% fetal bovine serum (Hyclone Laboratories) in a 37°C incubator under a 5% CO 2 atmosphere. HEK293 cells were from the American Type Culture Collection (CRL 1573), HEK293T cells were kindly provided by Dr. Robert Macdonald (Vanderbilt University), and tsA201 cells were kindly provided by Dr. J. Michael Edwardson (University of Cambridge). HEK293T and tsA201 are derived from the same line of HEK293 cells (293tsA1609neo) stably transfected with the temperature sensitive gene for SV40 T-antigen [13] . We will refer to this line as tsA201 henceforth to distinguish from our standard HEK293 cells.
Radioligand binding assays
For radioligand binding assays, cells were cotransfected at 25-50% confluency with cDNA for α1, β2, and γ2L subunits in either pCEP4 or pUNIV using a standard CaHPO 4 method [19] . For [ 3 H]muscimol binding estimates of apparent affinity, we transfected cells with 4 μg/subunit in pCEP or pUNIV. For [ 3 H]flunitrazepam (FNZM) estimations of maximal binding, 6 μg/subunit in pCEP or 3 μg/subunit in pUNIV were used to maintain similar copy number. Cells were incubated at 31°C/4% CO 2 before harvesting.
Cells were harvested approximately 48 h after transfection, membrane homogenates were prepared, and homologous competition binding experiments were performed as described previously [2, 40] . In brief, membrane homogenates (100 μg) were incubated at room temperature for 1 h with sub- [2, 29, 30, 40] . Nonradioactive FNZM was obtained as a gift from Dr. Sepinwall (Hoffman-La Roche, Nutley, NJ), and nonradioactive muscimol was from Sigma.
Mammalian cell recording
Whole cell recording from tsA201 cells was performed as described previously for HEK293 cells [5] . Cells were plated in 35-mm culture dishes 24-72 h before transient transfection with pCEP or pUNIV cDNAs for rat α1, β2, and γ2L subunits. We used 200 ng of α1 and β2 to express αβ receptors and added 2,000 ng γ2L for αβγ receptors cotransfected with 100-200 ng pCEP-EGFP or pUNIV-EGFP for visualization of transfected cells using a mercury lamp. Cells were transfected at 70-90% confluency using 3 μl Lipofectamine2000 (Invitrogen). Cells were refed 4-8 h after transfection, passaged to new 35-mm plates, and replated on 12-mm circular cover glass (Fisher Scientific, Pittsburgh, PA) 1 to 4 h before experiments, and maintained at 31°C to prevent overgrowth.
Solutions were applied using a two-barrel theta application pipette (Warner Instruments, Holliston, MA) connected to a piezoelectric stacked translator (Physik Instrumente, Costa Mesa, CA). The rapid application system was constructed of Teflon and polyimide tubing (Cole-Parmer, Vernon Hills, IL) connected to the theta glass. The voltage input to the high voltage amplifier (Physik Instrumente) used to drive the stacked translator was filtered (90 Hz) using an 8-pole Bessel Filter (Frequency Devices, Haverhill, MA) to reduce oscillations arising from rapid acceleration of the pipette. After obtaining stable whole cell access, negative holding pressure was applied, and the cell was lifted from the coverslip and positioned in front of the application pipette.
The recording chamber was perfused continuously with 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES)-buffered saline containing (mM): 145 NaCl, 5 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 HEPES; pH 7.4. This standard saline was also used as the "control" solution in the rapid application pipette. Recording pipettes were filled with: (mM) KCl 130, ethylene glycol bis(2-aminoethyl ether)-N,N,N′N′-tetraacetic acid 5, HEPES 10, MgCl 2 1, MgATP (ATP, adenosine triphosphate) 5; pH 7.2. GABA solutions were prepared daily from powder and diluted to desired concentrations in the same control/bath solution. Recordings were performed at room temperature on the stage of a Nikon TE-2000-S microscope.
Recording electrodes were fabricated from KG-33 glass (Garner Glass Company, Claremont, CA) using a multistage puller (Flaming-Brown model P-87, Sutter Instruments, Novato, CA) and coated with Sylgard 184 (Dow Corning, Midland, MI) to reduce electrode capacitance. The tips were fire polished. Open tip electrode resistance was typically 1-4 MΩ when filled with standard recording solution. All recordings were obtained at a holding potential of −40 mV unless otherwise specified using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Access resistance, typically 2-3 MΩ, was compensated >80% using amplifier circuitry. Data were low-pass filtered at 2-5 kHz, sampled at 5-10 kHz, and stored online using pClamp 9 software (Axon Instruments).
Oocyte expression and voltage-clamp
Mature stage V-VI oocytes from Xenopus laevis were defolliculated using 1 mg/ml collagenase Type 1A (Sigma, St. Louis, MO). cRNA was transcribed from Not Ilinearized pUNIV or Nhe I-linearized pGH19 using the T7 mMessage mMachine kit (Ambion, Austin, TX). Defolliculated oocytes were injected with 27.4 nl of cRNA at a concentration of 50 pg/nl per subunit of α1 and β2 subunits for αβ receptors or 5:5:50 pg/nl (α1/β2/γ2) to produce α1β2γ2 receptors [4] . Oocytes were incubated at 18°C in ND96 (in mM: 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 5 HEPES, pH 7.2) supplemented with 100 μg/ml gentamycin and 100 μg/ml bovine serum albumin for 2-14 days before use. GABA (Sigma) solutions were prepared daily in ND96.
Oocytes were continuously perfused at a rate of 5 ml/ min with ND96 in a 1.5 mm wide ×1.5-mm deep trough in Plexiglas with a metal post to hold the oocyte in place under flow. Oocytes were held under two-electrode voltage clamp at −80 mV. Borosilicate electrodes (Warner Instruments, Hamden, CT) were filled with 3 M KCl and had resistances between 0.7 to 2 MΩ. Electrophysiological data were acquired with a GeneClamp 500 (Axon Instruments) interfaced to a computer with an ITC16 analog-to-digital device (Instrutech, Great Neck, NY) and recorded using Whole Cell Program 3.2.9 (kindly provided by J. Demspter; University of Strathclyde, Glasgow, Scotland).
Concentration-response experiments were performed as described previously [3, 32] . In brief, GABA concentrationresponses were scaled to a low, nondesensitizing concentration of GABA (EC 2 -EC 10 ) applied just before the test concentration to correct for any slow drift in I GABA over the course of the experiment. Currents elicited by each test concentration were normalized to the corresponding low concentration current before curve fitting. Concentrationresponse data were fit to the following equation:
where I is the peak response to a given concentration of GABA; I max is the maximum amplitude of current; median effective concentration (EC 50 ) is the concentration of GABA that evokes halfmaximal response; [A] is the agonist concentration; and n is the Hill coefficient (Graphpad Prism).
Statistics
Comparisons between two data sets used either an unpaired t-test (nonparametric, Mann-Whitney test) or a paired t-test with a nonparametric correction (Wilcoxon matched pair test) when appropriate (Graphpad Prism). For comparisons of multiple data sets, one-way analysis of variance was employed, with Dunnett's or Bonferroni post-tests for significance of difference.
Results
Vector construction
The universal vector pUNIV was constructed using pCIneo as backbone ( Fig. 1 ; see Materials and methods). The Xenopus β-globin 3′-UTR and polyA tail was inserted to improve cRNA stability [28] and boost expression in oocytes [31, 43] . A modified AMV sequence was engineered into the 5′ PCR primer for each insert (in this case, EGFP or GABA A R subunit cDNAs) and incorporated in place of any native Kozak sequences [27] . pUNIV constructs were then linearized with Not I for cRNA transcription and injection into Xenopus oocytes or transfected whole into HEK293 or tsA201 cells.
Mammalian cell experiments
We first confirmed expression of GABA A Rs composed of α1 and β2 subunits using a radioligand binding assay and compared pUNIV expression directly to our standard vector, pCEP4 [1, 5] . We measured the apparent affinity (K d ) for muscimol, an agonist at the GABA binding site, by homologous competition of [ 3 H]muscimol with cold muscimol (Fig. 2a) . No significant difference was found between pCEP4 and pUNIV in three comparisons (all in HEK293 cells), with a pooled K d of 67.4±12.2 nM, similar to values previously obtained [40] . We also tested the ability of the large T-antigen stably expressed in tsA201 cells to enhance expression of subunit cDNAs in pUNIV by assaying benzodiazepine binding to α1β2γ2L receptors. Benzodiazepines require a γ subunit for their activity at the GABA A R [34] and bind to fully assembled pentameric receptors, whereas muscimol can bind to αβ receptors or partially assembled receptors [23] . We found dramatically increased [ 3 H]FNZM binding of pUNIV-transfected tsA201 cells compared to pCEP4-transfected HEK293 cells (Fig. 2b) , indicating a higher maximal number of binding sites expressed. B max with pUNIV was significantly higher (3.4-fold, p=0.007) than with pCEP4 in paired determinations (n=4).
Before performing electrophysiological recordings, we optimized transfection efficiency using EGFP-containing constructs. In multiple experiments, we found significantly lower expression of pUNIV-EGFP in our standard HEK293 cell line compared to pCEP4 (data not shown). Conversely, pCEP4-EGFP expression in tsA201 cells was less than optimal. However, pairing pUNIV constructs with tsA201 cells gave robust expression. GABA-gated currents from pUNIV GABA A R constructs were indistinguishable from previous recordings with pCEP4 constructs in HEK293 cells and were robust for at least 7 days (Fig. 3a) . We further confirmed that macroscopic desensitization (Fig. 3b) and deactivation kinetics (Fig. 3c) were not altered from the use of AMV.
Expression in Xenopus oocytes
Having established that pUNIV would provide long-term expression in mammalian cells, we next compared pUNIV to the high-level expression vector for oocyte studies, pGH19. Currents expressed in oocytes were qualitatively similar for pUNIV and pGH19 (Fig. 4a) . Concentrationresponse profiles (Fig. 4b) showed no significant differences (p>0.
In a 2-week time-course, we found that pUNIV cRNA was at least as long lasting as pGH19 for both α1β2 (Fig. 4c ) and α1β2γ2S receptors (data not shown). However, the pUNIV expression was significantly higher throughout the course of the experiment, with the exception of the first day postinjection (Fig. 4c) . Maximal currents for α1β2 receptors from pGH19 constructs were 10.3±1.1 μA (mean±s.e.m.) on day 5 postinjection, whereas pUNIV constructs yielded 14.7±1.0 μA. By day 13, average currents from pGH19 constructs were 7.5±1.1 μA versus 13.0±0.9 μA for pUNIV constructs. Similar results, with pUNIV constructs outstripping pHGH19 constructs, were obtained for α1β2γ2S receptors (data not shown).
Discussion
We have engineered a general use vector for both mammalian and oocyte expression systems. This allows for more direct comparison of proteins of interest or mutations from one system to the other without timeintensive subcloning or the need for shuttle vectors. Furthermore, any vector-dependent changes in protein expression, modification, or posttranslational behavior should be eliminated. Compared to two available vectors already optimized for high-expression in mammalian cells (pCEP4) or Xenopus laevis oocyte expression (pGH19), the new vector pUNIV performed as well or better. Expression was long lasting, exceeding 1 week, and quite robust. Receptors were also shown to behave similarly to previous work, using more sensitive kinetic comparisons (Fig. 3) .
The long-term stability of cRNAs in oocytes from both pUNIV and pGH19 may be due to the addition of the Xenopus β-globin 3′-UTR and polyA signal. We speculate that the increased expression in oocytes using the pUNIV vector ( Fig. 4c) was due to the inclusion of the AMV sequence before the start methionine. It is possible that the AMV sequence also accounts for much of the increase in expression seen in HEK293 cell lines (Fig. 2b) . The unstructured nature of the AMV RNA 4 leader sequence may allow for more competitive expression compared to native mRNAs, because it does not require unwinding or association with cap-binding proteins [16, 35] , or it may have increased affinity for other (perhaps limiting) components of the translation machinery [25] . For example, efficient in vitro translation using AMV has a reduced requirement for elongation factors [7] . Other vectors have employed "optimized" Kozak sequences for enhancing expression [11, 17] ; we found that replacing any of our native Kozak sequences with AMV in pUNIV worked more efficiently.
We excluded any GFP coexpression element in pUNIV unlike other vectors [24] , as this may interfere with fluorescence studies and has also been suggested to produce cytotoxic effects [20, 26] . For identification of transfected HEK293 cells for electrophysiology experiments, we used EGFP coexpression at controlled, lower levels. However, other identification methods could easily have been used, such as antitag antibody bead-labeling. For bacterial expression using the T7 promoter, any of a variety of do not differ significantly between vectors (α1β2, p=1.0; α1β2γ2L, p=0.057). Data are mean±s.e.m., n≥3. c Weighted deactivation time constants (τ) for α1β2 and α1β2γ2L transfections using the two expression vectors. pUNIV α1β2 (closed circles) and pCEP4 α1β2 (open circles) deactivation do not differ significantly (p>0.05) at any pulse duration tested nor do pUNIV α1β2γ2L (closed squares) compared to pCEP4 α1β2γ2L (open squares). Data are mean±s.e.m., n=3-12. In some cases, error bars are smaller than symbols Fig. 4 Expression of GABA A Rs in Xenopus oocytes is long-lasting and robust. a Typical current traces from oocytes injected with cRNA from pUNIV-α1 plus pUNIV-β2 (solid trace) normalized and compared to pGH19-α1 plus pGH19-β2 (dashed trace). Cells were exposed to 1 mM GABA for 20 s then washed back into recording solution. b Concentration-response curves for α1β2 (circles) versus α1β2γ2S GABA A Rs (squares) expressed from pUNIV (open symbols) or pGH19 (closed symbols). Peak currents at varying GABA concentrations were normalized to 10 mM GABA and fit with a sigmoidal concentration-response equation (see Materials and methods). EC 50 values and Hill slopes for either receptor type were not significantly different between the two vectors. Data are mean±s.e.m., n≥3. c Time-course for expression levels of α1β2 receptors. Peak currents with 10 mM GABA were measured for cells injected with cRNA from pUNIV (closed circles) versus pGH19 (open squares) over a 2-week time period. pUNIV currents were statistically larger than pGH19 currents for days 3, 5, 10, and 13 postinjection (asterisk). p values were as follows: day 1, p=0.079; day 3, p=0.014; day 5, p=0.0037; day 10, p=0.0034; day 13, p=0.0021. Data are mean±s.e.m. Number of experiments per time point (n) in parentheses protein purification tags can be incorporated into the 5′ oligonucleotide, such as a maltose-binding protein tag to increase protein solubility [11] .
Concluding remarks
High-level expression is particularly useful when studying ion channels with low amplitude or mutations that reduce expression levels, and long-lasting expression is necessary when multiple recordings over a time-course would be required (e.g. after reinjection with an additional cRNA). By boosting expression, pUNIV will also provide an advantage when expressing proteins on a larger preparative scale. On the other end of the spectrum, higher expression levels require less of any limiting reagent, and increased signal-to-noise ratios will be beneficial for studies, such as radioligand binding assays or labeled fluorescence experiments. Ability to study a protein across expression systems is not only timesaving but may alert us to differences that are system-dependent.
